Trident Texofab Statistics
Total Valuation
Trident Texofab has a market cap or net worth of INR 372.94 million. The enterprise value is 817.10 million.
| Market Cap | 372.94M |
| Enterprise Value | 817.10M |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Trident Texofab has 15.00 million shares outstanding. The number of shares has increased by 4.66% in one year.
| Current Share Class | 15.00M |
| Shares Outstanding | 15.00M |
| Shares Change (YoY) | +4.66% |
| Shares Change (QoQ) | +1.28% |
| Owned by Insiders (%) | 40.48% |
| Owned by Institutions (%) | n/a |
| Float | 8.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.73 |
| EV / EBITDA | 21.88 |
| EV / EBIT | 37.57 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.20, with a Debt / Equity ratio of 0.79.
| Current Ratio | 2.20 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | 11.94 |
| Debt / FCF | n/a |
| Interest Coverage | 0.75 |
Financial Efficiency
Return on equity (ROE) is -0.55% and return on invested capital (ROIC) is 2.25%.
| Return on Equity (ROE) | -0.55% |
| Return on Assets (ROA) | 1.18% |
| Return on Invested Capital (ROIC) | 2.25% |
| Return on Capital Employed (ROCE) | 2.75% |
| Weighted Average Cost of Capital (WACC) | 3.00% |
| Revenue Per Employee | 21.06M |
| Profits Per Employee | -59,151 |
| Employee Count | 53 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 5.60 |
Taxes
In the past 12 months, Trident Texofab has paid 2.92 million in taxes.
| Income Tax | 2.92M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.25% in the last 52 weeks. The beta is -0.69, so Trident Texofab's price volatility has been lower than the market average.
| Beta (5Y) | -0.69 |
| 52-Week Price Change | -92.25% |
| 50-Day Moving Average | 20.66 |
| 200-Day Moving Average | 49.88 |
| Relative Strength Index (RSI) | 70.23 |
| Average Volume (20 Days) | 35,155 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Trident Texofab had revenue of INR 1.12 billion and -3.14 million in losses. Loss per share was -0.21.
| Revenue | 1.12B |
| Gross Profit | 95.13M |
| Operating Income | 21.75M |
| Pretax Income | -217,000 |
| Net Income | -3.14M |
| EBITDA | 36.03M |
| EBIT | 21.75M |
| Loss Per Share | -0.21 |
Balance Sheet
The company has 1.57 million in cash and 445.73 million in debt, with a net cash position of -444.16 million or -29.62 per share.
| Cash & Cash Equivalents | 1.57M |
| Total Debt | 445.73M |
| Net Cash | -444.16M |
| Net Cash Per Share | -29.62 |
| Equity (Book Value) | 567.08M |
| Book Value Per Share | 37.55 |
| Working Capital | 461.78M |
Cash Flow
In the last 12 months, operating cash flow was -125.36 million and capital expenditures -13.66 million, giving a free cash flow of -139.03 million.
| Operating Cash Flow | -125.36M |
| Capital Expenditures | -13.66M |
| Depreciation & Amortization | 14.28M |
| Net Borrowing | 124.07M |
| Free Cash Flow | -139.03M |
| FCF Per Share | -9.27 |
Margins
Gross margin is 8.52%, with operating and profit margins of 1.95% and -0.28%.
| Gross Margin | 8.52% |
| Operating Margin | 1.95% |
| Pretax Margin | -0.02% |
| Profit Margin | -0.28% |
| EBITDA Margin | 3.23% |
| EBIT Margin | 1.95% |
| FCF Margin | n/a |
Dividends & Yields
Trident Texofab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.66% |
| Shareholder Yield | -4.66% |
| Earnings Yield | -0.84% |
| FCF Yield | -37.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on August 11, 2020. It was a forward split with a ratio of 2.4.
| Last Split Date | Aug 11, 2020 |
| Split Type | Forward |
| Split Ratio | 2.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |